Research and Markets has announced the addition of the "Bone Marrow Transplant Rejection - Pipeline Review, H2 2016" report to their offering.
Bone Marrow Transplant Rejection Bone marrow transplant rejection is a complication that can occur after a stem cell or bone marrow transplant. The newly transplanted donor cells attack the transplant recipient's body. Symptoms include chest pain, chills, drop in blood pressure, fever, flushing, funny taste in the mouth, headache, hives, nausea, pain and shortness of breath. Treatment includes immunosuppressive drugs.
Bone Marrow Transplant Rejection pipeline therapeutics constitutes close to 107 molecules. Out of which approximately 89 molecules are developed by Companies and remaining by the Universities
Institutes. The molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 7, 22, 17, 36, 5 and 2 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 3, 3, 11 and 1 molecules, respectively.
Bone Marrow Transplant Rejection - Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Bone Marrow Transplant Rejection, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews of key players involved in therapeutic development for Bone Marrow Transplant Rejection and features dormant and discontinued projects.
Key Topics Covered:
For more information about this report visit http://www.researchandmarkets.com/research/vxhvzv/bone_marrow
View source version on businesswire.com: http://www.businesswire.com/news/home/20161013005997/en/Business Wire
Last updated on: 13/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.